Xilong Wang
No. 801, Heqing Road
Minhang, 200240, China
Minhang, 200240, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Elevated VRK1 levels after androgen deprivation therapy promote prostate cancer progression by upregulating YAP1 expression.
Journal: Journal of cancer research and clinical oncology
Published: February 08, 2025
Potential biomarkers and the molecular mechanism associated with DLL4 during renal cell carcinoma progression.
Journal: The American journal of the medical sciences
Published: December 15, 2020
The Correlation between Severity of Overactive Bladder Symptoms with Female Sexual Dysfunction and Sexual Satisfaction of Partners.
Journal: Urologia internationalis
Published: February 21, 2020
KLF16 Affects the MYC Signature and Tumor Growth in Prostate Cancer.
Journal: OncoTargets and therapy
Published: October 05, 2019
1470 nm Diode Laser Enucleation vs Plasmakinetic Resection of the Prostate for Benign Prostatic Hyperplasia: A Randomized Study.
Journal: Journal of endourology
Published: November 30, 2018
Targeting POH1 inhibits prostate cancer cell growth and enhances the suppressive efficacy of androgen deprivation and docetaxel.
Journal: The Prostate
Published: September 26, 2018
Upregulated VEGFA and DLL4 act as potential prognostic genes for clear cell renal cell carcinoma.
Journal: OncoTargets and therapy
Published: April 06, 2018
Tissue-engineered sling with adipose-derived stem cells under static mechanical strain.
Journal: Experimental and therapeutic medicine
Published: April 11, 2016
The HSP90 inhibitor 17-PAG effectively inhibits the proliferation and migration of androgen-independent prostate cancer cells.
Journal: American journal of cancer research
Published: August 20, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026